ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 3 for:    small cell lung cancer BMN 673
Previous Study | Return to List | Next Study

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03672773
Recruitment Status : Not yet recruiting
First Posted : September 14, 2018
Last Update Posted : October 16, 2018
Sponsor:
Collaborators:
Translational Research in Oncology
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : November 1, 2019
  Estimated Study Completion Date : November 1, 2020